Publications & Works

Publication Network
Articles 41
All (41)
SCI-E, SSCI, AHCI (32)
SCI-E, SSCI, AHCI, ESCI (36)
ESCI (4)
Scopus (36)
TRDizin (17)
Other Publications (2)

1. Direct Second Autologous Stem Cell Transplantation Versus Re-Induction Followed by Transplantation in Relapsed Multiple Myeloma: A Multicenter Real-World Study

Kars T. U., GÖKER H., DEMİROĞLU H., MALKAN Ü. Y., ALADAĞ KARAKULAK E., Erdekli F. T., et al.
Journal of Clinical Medicine , vol.15, no.13, 2026 (SCI-Expanded, Scopus)

2. Posaconazole Therapeutic Drug Monitoring in Daily Practice: A Single-Center Analysis

Balaban U., Kara E., Pinar A., Gülmez Kıvanç D., Karakulak E. A., Akdagli S. A., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.42, pp.818-825, 2026 (SCI-Expanded, Scopus) Sustainable Development

3. Assessment of characteristics and treatment patterns of adult patients with acquired aplastic anemia in Turkiye (PLANE-TR)

GÜNDÜZ E., Ulas T., ÖZKALEMKAŞ F., TOPRAK S. K., Karakulak E. A., AR M. C., et al.
Annals of Hematology , vol.105, no.4, 2026 (SCI-Expanded, Scopus) Creative Commons License

4. Case Report: Steroid Responsive Pompe Like Inflammatory Myositis With Complete Recovery After Allogeneic HSCT

KART BAYRAM G. S., FIRLATAN YAZGAN B., ALADAĞ KARAKULAK E., Bekircan-Kurt C. E., AKDOĞAN A.
International Journal of Rheumatic Diseases , vol.29, no.4, 2026 (SCI-Expanded, Scopus)

5. Chronic Myeloid Leukemia Transforming into Acute Lymphoblastic Leukemia in a Patient with Gaucher Disease: A Case Report and Literature Review

Sayinalp Arslan B., ÇATAN ERDEKLİ F. T., Sağlam Ayhan A., ALADAĞ KARAKULAK E., MALKAN Ü. Y., BÜYÜKAŞIK Y.
Case Reports in Oncology , pp.437-443, 2026 (ESCI, Scopus)

6. Glimpse into Routine EMG Findings of Patients with Malign Neoplasms

Uyanık H. U., Temucin C. M., arık z., Aladag E., Yildiz F. G.
Uluslararası Hematoloji-Onkoloji Dergisi , vol.35, no.2, pp.150-157, 2025 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

7. Anemia in the patients with acute myeloid leukemia revisited: Prognostic importance of anemia on treatment-naïve patients

Çınar O. E., Malkan U. Y., Aladag E., Demiroglu H., Büyükaşık Y., Göker H., et al.
Acta Medica , vol.56, no.2, pp.116-121, 2025 (TRDizin)

8. Turkish translation, validity, and reliability of the European organization for research and treatment of cancer quality of life-high dose chemotherapy29 in patients undergone hematopoietic stem cell transplantation

Kabak V. Y., Karahan S., Aladag E., Duger T., Uysal S. A., Erdem F. I., et al.
Turkish Journal of Medical Sciences , vol.55, no.3, pp.540-546, 2025 (SCI-Expanded, Scopus, TRDizin)

9. DOES THE PRESENCE OF ANEMIA HAVE AN IMPACT ON PHYSICAL FUNCTIONS IN PATIENTS TREATED WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION?

YILDIZ KABAK V., ATASAVUN UYSAL S., ALADAĞ KARAKULAK E., GÖKER H., DÜGER T.
TURKISH JOURNAL OF PHYSIOTHERAPY REHABILITATION-TURK FIZYOTERAPI VE REHABILITASYON DERGISI , vol.35, no.3, pp.290-296, 2024 (ESCI, Scopus, TRDizin)

10. Four‑Dimensional Echocardiographic Evaluation of Cardiac Iron Overload in Patients with Beta-Thalassemia Major

FEDAİ A. B., KARAKULAK U. N., Aladag E., SAYINALP N.
Cardiovascular Toxicology , vol.24, no.1, pp.41-48, 2024 (SCI-Expanded, Scopus)

11. Exploring the distribution and prognostic effect of the ABO blood types of COVID-19 patients during delta and omicron waves: A case control study

GÖKER H., ÇINAR O. E., ISMAYILOV R., Özdemir E., MALKAN Ü. Y., ALADAĞ E., et al.
Acta Medica , vol.54, no.2, pp.97-102, 2023 (Peer-Reviewed Journal) Creative Commons License

12. A single-center experience of haploidentical stem cell transplantation in hematological malignancies

MALKAN Ü. Y., GÖKER H., DEMİROĞLU H., Tekin F., Akdemir B., ALADAĞ KARAKULAK E., et al.
Turkish Journal of Medical Sciences , vol.53, no.1, pp.352-359, 2023 (SCI-Expanded, Scopus, TRDizin)

13. Comparison of Visual Rating Scale Based on Brain 18F-FDG-PET and Montreal Cognitive Assessment Test in Probable Alzheimer’s Disease

ALADAĞ KARAKULAK E., Bulut E., Demirayak P., VOLKAN SALANCI B., KARLI OĞUZ H. K., ERBAŞ H. B., et al.
Acta Medica , vol.53, 2022 (TRDizin)

14. Bone Marrow Origin of Coronary Artery Diseases: The Impact of the Local Renin-Angiotensin System

KARAKULAK U. N., ALADAĞ KARAKULAK E., HAZNEDAROĞLU İ. C.
ACTA CARDIOLOGICA SINICA , vol.38, no.1, pp.13-20, 2022 (SCI-Expanded, Scopus)

15. Long-term results of allogeneic peripheral blood hematopoietic stem cell transplantation for severe aplastic anemia

ALADAĞ KARAKULAK E., GÖKER H., DEMİROĞLU H., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.2, 2021 (SCI-Expanded, Scopus)

16. Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors

KARAKULAK U. N., ALADAĞ KARAKULAK E., HEKİMSOY V., ŞAHİNER M. L., KAYA E. B., ÖZER N., et al.
CARDIOVASCULAR TOXICOLOGY , vol.21, no.3, pp.216-223, 2021 (SCI-Expanded, Scopus)

17. Allogeneic Hematopoietic Stem-Cell Transplantation Improves Disease-Free Survival Compared to Pediatric-Inspired Berlin-Frankfurt-Munster Chemotherapy in Adult Acute Lymphoblastic Leukemia

ALADAĞ KARAKULAK E., Aktimur S. H., Aydin O., DEMİROĞLU H., BÜYÜKAŞIK Y., AKSU S., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, no.3, pp.147-153, 2021 (SCI-Expanded, Scopus)

18. Assessment of ST2 and Reg3a levels in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

ALADAĞ KARAKULAK E., DEMİROĞLU H., Malkan Ü. Y., Akman U., GÖKER H., BÜYÜKAŞIK Y.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.1, pp.355-358, 2021 (SCI-Expanded, Scopus, TRDizin)

19. Comparison of single and double autologous stem cell transplantation in multiple myeloma patients

Malkan Ü. Y., DEMİROĞLU H., BÜYÜKAŞIK Y., KARATAŞ A., ALADAĞ KARAKULAK E., GÖKER H.
OPEN MEDICINE , vol.16, no.1, pp.192-197, 2021 (SCI-Expanded, Scopus) Creative Commons License

20. Effect of Salvage Chemotherapy Before Donor Lymphocyte Infusion in Patients With Relapse After Allogeneic Hematologic Stem Cell Transplantation

ALADAĞ KARAKULAK E., GÖKER H., BÜYÜKAŞIK Y., DEMİROĞLU H.
TRANSPLANTATION PROCEEDINGS , vol.53, no.1, pp.391-395, 2021 (SCI-Expanded, Scopus)

21. Comparison of Risk Scoring Systems in HLA-Matched Related Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study

ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., GÖKER H.
TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.2, pp.138-144, 2021 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

22. Assessment of Diastolic Function and Thiol-Disulphide Homeostasis in Arsenic-Exposed Workers

KARAKULAK U. N., BAL C., Gunduzoz M., Buyuksekerci M., ALADAĞ KARAKULAK E., ŞAHİNER M. L., et al.
ACTA CARDIOLOGICA SINICA , vol.37, no.1, pp.86-96, 2021 (SCI-Expanded, Scopus) Sustainable Development

23. Spontaneous subepithelial hemorrhage of renal pelvis and ureter (Antopol-Goldman lesion) in hemophilia A patient with inhibitor Case report and review of the literature

ŞAHİN T. K., ALADAĞ KARAKULAK E., Setterzade E., SAİN GÜVEN G., HAZNEDAROĞLU İ. C., AKSU S.
MEDICINE , vol.99, no.26, 2020 (SCI-Expanded, Scopus)

24. Cardiac adverse events during stem cell transplantation for hematological malignancies: A single centre experience

ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., KARAKULAK U. N., Tekin F., AKSU S., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.59, no.2, 2020 (SCI-Expanded, Scopus)

25. Acute Graft-Versus-Host Disease: A Brief Review

ALADAĞ KARAKULAK E., KELKİTLİ E., GÖKER H.
TURKISH JOURNAL OF HEMATOLOGY , vol.37, no.1, pp.1-4, 2020 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

26. SECONDARY MALIGNANCIES IN PATIENTS WITH MULTIPLE MYELOMA

ALADAĞ KARAKULAK E., BÜYÜKAŞIK Y., DEMİROĞLU H., AKSU S., GÖKER H.
AMERICAN JOURNAL OF HEMATOLOGY , vol.94, 2019 (SCI-Expanded, Scopus)

27. Impact of Pre-transplant and Post-transplant Remission Status of Patients on Survival in Newly Diagnosed Multiple Myeloma

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., DEMİROĞLU H.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.35, no.4, pp.655-661, 2019 (SCI-Expanded, Scopus)

28. DETERMINANTS OF CARDIORESPIRATORY FITNESS LEVEL IN HEMATOPOIETIC STEM CELL TRANSPLANTATION CANDIDATES

YILDIZ KABAK V., GÖKER H., ATASAVUN UYSAL S., DEMİROĞLU H., ALADAĞ KARAKULAK E., OKAY M., et al.
TURKISH JOURNAL OF PHYSIOTHERAPY REHABILITATION-TURK FIZYOTERAPI VE REHABILITASYON DERGISI , vol.30, no.2, pp.81-88, 2019 (ESCI, Scopus, TRDizin)

29. Impact of bone marrow plasma cells percentage on survival at diagnosis and pre-transplant period in newly diagnosed multiple myeloma: Experience of a single center from Turkey

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., Saglam E. A., DEMİROĞLU H.
TRANSFUSION AND APHERESIS SCIENCE , vol.58, no.3, pp.313-317, 2019 (SCI-Expanded, Scopus)

30. CYTOGENETIC ANOMALIES IN MULTIPLE MYELOMA PATIENTS: A SINGLE CENTER STUDY

BOZKURT S., BÜYÜKAŞIK Y., DEMİROĞLU H., ALADAĞ KARAKULAK E., OKAY M., KARATAŞ A., et al.
Genetics and Application , vol.3, no.1, pp.51-56, 2019 (Peer-Reviewed Journal)

31. Efficacy and Feasibility of Allogeneic Hematopoietic Stem-Cell Transplantation in the Treatment of Refractory Acute Myeloid Leukemia

Ciftciler R., DEMİROĞLU H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., AKSU S., HAZNEDAROĞLU İ. C., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.19, no.3, pp.177-182, 2019 (SCI-Expanded, Scopus)

32. Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study

Ciftciler R., GÖKER H., DEMİROĞLU H., ALADAĞ KARAKULAK E., AKSU S., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.36, no.2, pp.88-96, 2019 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

33. Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., Malkan Ü. Y., Ciftciler R., ALADAĞ KARAKULAK E., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.4, pp.985-992, 2019 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

34. Current perspectives for the treatment of chronic myeloid leukemia

ALADAĞ KARAKULAK E., HAZNEDAROĞLU İ. C.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.1, pp.1-10, 2019 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

35. Unclassifiable non-CML classical myeloproliferative diseases with microcytosis: findings indicating diagnosis of polycythemia vera masked by iron deficiency

ALADAĞ KARAKULAK E., AKSU S., DEMİROĞLU H., SAYINALP N., GÖKER H., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.5, pp.1560-1563, 2019 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

36. Waldenstrom macroglobulinemia presenting as plasma cell leukemia associated with hyperviscosity syndrome

ÇİFTÇİLER R., SAĞLAM E. A., ALADAĞ KARAKULAK E., HAZNEDAROĞLU İ. C.
Medical Science and Discovery , vol.5, no.12, pp.390-392, 2018 (Peer-Reviewed Journal) Creative Commons License

37. Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy

KARAKULAK U. N., ALADAĞ KARAKULAK E., Maharjan N., ÖVÜNÇ K.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.44, no.1, pp.71-74, 2016 (ESCI, Scopus, TRDizin) Sustainable Development

38. Evaluation of the ambulatory arterial stiffness index in patients with rheumatoid arthritis

KARAKULAK U. N., Sahiner L., Maharjan N., OKUTUCU S., EVRANOS B., ALADAĞ KARAKULAK E., et al.
BLOOD PRESSURE MONITORING , vol.20, no.5, pp.254-259, 2015 (SCI-Expanded, Scopus) Sustainable Development

39. Assessment of Cardiac Autonomic Nervous System Involvement in Systemic Sclerosis via Exercise Heart Rate Recovery

KARAKULAK U. N., OKUTUCU S., Sahiner L., Maharjan N., ALADAĞ KARAKULAK E., AKDOĞAN A., et al.
MEDICAL PRINCIPLES AND PRACTICE , vol.24, no.1, pp.17-22, 2015 (SCI-Expanded, Scopus) Creative Commons License

40. Dizygotic twin with congenital AV block

KARAKULAK U. N., Cengaver M. K., ALADAĞ KARAKULAK E., Maharjan N.
ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY , vol.15, no.1, pp.89, 2015 (SCI-Expanded, Scopus) Creative Commons License

41. The phantom of the chest

KARAKULAK U. N., Maharjan N., ALADAĞ KARAKULAK E., EVRANOS B.
ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY , vol.14, no.7, pp.657-658, 2014 (SCI-Expanded, Scopus, TRDizin)
Papers Presented at Peer-Reviewed Scientific Conferences 38

1. Hematopoetik kök hücre nakli yapılan hastalarda nakil tipine göre yorgunluk düzeyinin karşılaştırılması.

YILDIZ KABAK V., DEMİRCİOĞLU KARAGÖZ A., KUMBAROĞLU F. B., ALADAĞ KARAKULAK E., KARAHAN S., GÖKER H., et al.
9. Ulusal Fizyoterapi ve Rehabilitasyon Kongresi, Denizli, Turkey, 26 October 2023, (Summary Text)

2. AZACYTIDINE BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION IS INFERIOR TO HD/ARA-C WITHRESPECT TO RELAPSE FOLLOWING TRANSPLANTATION

DEMİROĞLU H., OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., GÜL Ö., BÜYÜKAŞIK Y., et al.
24th EHA Congress, 13 - 16 June 2019, vol.3, pp.941-942, (Summary Text)

3. THE EVALUATION OF THE CLINICOPATHOLOGIC CHARACTERISTICS OF T-CELL NON-HODGKIN’S LYMPHOMA: THE SINGLE CENTER EXPERIENCE

SAYINALP N., ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., AKSU S., DEMİROĞLU H., et al.
15th International Conference on Malignant Lymphoma, Switzerland, 18 - 22 June 2019, vol.37, pp.366, (Summary Text)

4. ASEMPTOMATİK D-DİMER YÜKSEKLİĞİ İMMÜNMONULATUAR KULLANAN MULTİPLE MYELOMADA TROMBOZU TAHMİN EDER Mİ: GERÇEK YAŞAM VERİSİ

AYDIN M. S., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., YAZGAN S. Ç., DEMİROĞLU H., ÖZCEBE O. İ., et al.
4. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Cyprus (Kktc), 4 - 06 April 2019, (Summary Text)

5. HEMATOLOJİK MALİGNİTELERDE DONÖR LENFOSİT İNFÜZYONU ÖNCESİ VERİLEN KEMOTERAPİ SİKLUS SAYISININ SAĞKALIMA ETKİSİ

ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., BÜYÜKAŞIK Y., GÖKER H., DEMİROĞLU H.
4. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Cyprus (Kktc), 4 - 06 April 2019, (Summary Text)

6. ALLOJENİK KÖK HÜCRE NAKLİ SONRASI RELAPS İZLENEN AKUT LÖSEMİ HASTALARINDA TEDAVİ SEÇENEKLERİ: DONÖR LENFOSİT İNFUZYONU VE İKİNCİ ALLOJENİK KÖK HÜCRE NAKLİNİN KARŞILAŞTIRILMASI

ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., OKAY M., ÇİFTÇİLER R., SAYINALP N., et al.
4. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Cyprus (Kktc), 4 - 06 April 2019, (Summary Text)

7. MULTİPLE MYELOM HASTALARINDA İNDUKSİYON TEDAVİ SÜRESİNİN SAĞKALIMA ETKİSİ

ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., DEMİROĞLU H., AKSU S., BÜYÜKAŞIK Y., et al.
3. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Turkey, 8 - 09 March 2019, (Summary Text)

8. Long-Term Results of Non-Fludarabine Versus Fludarabine-Based Conditioning Regimens in Severe Aplastic Anemia Patients

ALADAĞ KARAKULAK E., DEMİROĞLU H., Ciftciler R., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., et al.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132, (Summary Text)

9. PHILADELPHIA KROMOZOMU POZİTİF AKUT MYELOİD LÖSEMİLİ OLGU

DEMİROĞLU H., GÖKER H., BÜYÜKAŞIK Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., OKAY M.
TÜRK HEMATOLOJİ DERNEĞİ, Turkey, 31 October - 03 November 2018, (Full Text)

10. MRG’DE TESADÜFEN SAPTANAN KEMİK İLİĞİNİN DİFFÜZ SİNYAL DEĞİŞİKLİKLERİ LENFOHEMATOPOETİK HASTALIKLARI ÖNGÖREBİLİR Mİ?

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., AKSU S., SAYINALP N., DEMİROĞLU H., GÖKER H., et al.
44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 31 October - 03 November 2018, pp.266, (Summary Text)

11. T HÜCRELİ LENFOMA HASTALARININ KLİNİK ÖZELLİKLERİNİN DEĞERLENDİRİLMESİ: TANIDAN PROGNOZA TEK MERKEZ DENEYİMİ

DEMİROĞLU H., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., et al.
TÜRK HEMATOLOJİ DERNEĞİ, Turkey, 31 October - 03 November 2018, (Full Text)

12. DASATİNİB KULLANIRKEN PLEVRAL EFFÜZYONU GELİŞİP, KÜÇÜK HÜCRELİ AKCİĞER KANSERİ TANISI ALAN BİR OLGU

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., SAYINALP N., HAZNEDAROĞLU İ. C., ÖZCEBE O. İ., AKSU S., et al.
44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 31 October - 03 November 2018, pp.364-365, (Summary Text) Sustainable Development

13. PRİMER VE EDİNSEL İMMÜN YETMEZLİĞİ OLAN HASTALARDA MALİGNİTE SIKLIĞI

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., HAZNEDAROĞLU İ. C., SAYINALP N.
44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 31 October - 03 November 2018, pp.276-277, (Summary Text)

14. AĞIR APLASTİK ANEMİ HASTALARINDA HEMATOPOETİK KÖK HÜCRE NAKLİNDE KULLANILAN HAZIRLIK REJİMLERİNİN KARŞILAŞTIRILMASI

ALADAĞ KARAKULAK E., DEMİROĞLU H., ÇİFTÇİLER R., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., et al.
44.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 31 October - 03 November 2018, pp.261, (Summary Text)

15. LENALİDOMİD İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİB’E KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIM

MALKAN Ü. Y., BÜYÜKAŞIK Y., DEMİROĞLU H., ÇİFTÇİLER R., GÜNEŞ G., OKAY M., et al.
44.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 31 October - 03 November 2018, pp.191-192, (Summary Text)

16. PHİLADELPHİA KROMOZOMU POZİTİF AKUT MYELOİDLÖSEMİLİ OLGU

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., OKAY M., GÖKER H., DEMİROĞLU H., BÜYÜKAŞIK Y.
44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 31 October - 03 November 2018, pp.340, (Summary Text)

17. Extramedullary relapse of the AML following allo-HSCT: a case repor

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., OKAY M., GÖKER H.
IX. International Eurasian Hematology-Oncology Congress, Turkey, 17 - 20 October 2018, vol.71, pp.43, (Summary Text)

18. RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANNTRON-MELFALAN HAZIRLAMA REJİMİ

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., malkan Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.
6. HEMATOLOJİK ONKOLOJİ KONGRESİ, Turkey, 18 - 22 September 2018, (Full Text)

19. RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANTRON-MELFALAN HAZIRLAMA REJİMİ

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.
5. HEMATOLOJİK ONKOLOJİ KONGRESİ, Cyprus (Kktc), 20 - 22 September 2018, (Summary Text)

20. AKUT MYELOİD LÖSEMİLİ BİR OLGULDA SİTOZİN ARABİNOZİD İLİŞKİLİ PULMONER TOKSİSİTE

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., HAZNEDAROĞLU İ. C., AKSU S., DEMİROĞLU H., GÖKER H., et al.
4.İLAÇ VE TEDAVİ KONGRESİ, Cyprus (Kktc), 19 - 23 September 2018, pp.254, (Summary Text)

21. COMPARISON OF MYELOABLATIVE AND REDUCED-INTENSITY CONDITIONING REGIMENS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

ÇİFTÇİLER R., OKAY M., ALADAĞ KARAKULAK E., BÜYÜKAŞIK Y., GÖKER H., DEMİROĞLU H.
EUROPEAN HEMATOLOGY ASSOCIATION, 14 - 17 June 2018, (Full Text)

22. EFFECT OF THE INDUCTION THERAPY ON SURVIVAL IN MULTIPLE MYELOMA PATIENTS

ALADAĞ KARAKULAK E., ÇİFTÇİLER R., DEMİROĞLU H., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.
The International Congress of BMT 2018, Busan, South Korea, 30 August - 01 September 2018, (Summary Text)

23. RISK FACTORS FOR EARLY MORTALITY IN MULTIPLE MYELOMA WITH DIFFERENT SURVIVAL TIME CUT-OFF POINTS: REAL-LIFE DATA

AYDIN M. S., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., DEMİROĞLU H., GÖKER H., TURGUT M., et al.
23rd Congress of EHA, Stockholm, Sweden, 14 - 17 June 2018, (Summary Text)

24. Posttransplant Ebstain-Barr viral load monitoring experience in a hematopoietic stem cell transplantation center

AYDIN M. S., Inkaya Çağkan a., ALADAĞ KARAKULAK E., çiftçiler R., TURGUT M., GÖKER H., et al.
European Hematology Association, 14 - 17 June 2018, (Summary Text)

25. POST-TRANSPLANT EBSTEIN-BARR VIRAL LOAD MONITORING EXPERIENCE IN A HEMATOPOIETIC STEM CELL TRANSPLANTATION CENTER

AYDIN M. S., İNKAYA A. Ç., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., TURGUT M., GÖKER H., et al.
23rd Congress of EHA, Stockholm, Sweden, 14 - 17 June 2018, (Summary Text)

26. The Novel Translocation Of T(121) In Multiple Myeloma With Complex Karyotype

OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., GÖKER H.
23rd Congress of EHA, Stockholm, Sweden, 14 - 17 June 2018, (Summary Text)

27. Does Asymptomatic D-Dimer Elevation Predict Thrombosis in Patient on Immunomodulatory Drugs in Multiple Myeloma: Real-Life Data

AYDIN M. S., YAZGAN S. C., ALADAĞ KARAKULAK E., Çiftçiler R., KELKİTLİ E., TURGUT M., et al.
European Hemtology Association, 14 - 17 June 2018, (Summary Text)

28. DOES ASYMPTOMATIC D-DIMER ELEVATION PREDICT THROMBOSIS IN PATIENTS ON IMMUNOMODULATORY DRUGS IN MULTIPLE MYELOMA: REAL-LIFE DATA

AYDIN M. S., YAZGAN S. Ç., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., KELKİTLİ E., TURGUT M., et al.
23rd Congress of EHA, Stockholm, Sweden, 14 - 17 June 2018, (Summary Text)

29. ANJİMMUNOBLASTİK T HÜCRELİ LENFOMA, ÇOK YÜZLÜ LENFOMA

OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., HEZİYEV T., GÖKER H., BÜYÜKAŞIK Y.
2. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Cyprus (Kktc), 4 - 06 May 2018, (Summary Text)

30. PLAZMA HÜCRELİ LÖSEMİ ŞEKLİNDE PREZENTE OLAN WALDENSTROM MAKROGOBULİNEMİSİ

ÇİFTÇİLER R., OKAY M., ALADAĞ KARAKULAK E., HEZİYEV T., AKSU S., SAYINALP N., et al.
2. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Cyprus (Kktc), 4 - 06 May 2018, (Summary Text)

31. KRONİK LENFOSİTİK LÖSEMİ HASTALARINDA İKİNCİL MALİGNİTELERİN DEĞERLENDİRİLMESİ

ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., HEZİYEV T., BÜYÜKAŞIK Y., SAYINALP N., et al.
2. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Cyprus (Kktc), 4 - 06 May 2018, (Summary Text)

32. Common medical problems in adult patients with Hemophilia A: A single center experience

AYDIN M. S., OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., DEMİROĞLU H., GÖKER H., et al.
15. INTERNATIONAL HEMOPHILIA CONGRESS OF TURKEY, İstanbul, Turkey, 4 - 07 April 2018, (Summary Text)

33. HIV-NEGATİF PLASMABLASTİK LENFOMA

OKAY M., ÜNER A., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., DEMİROĞLU H.
3. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Cyprus (Kktc), 29 - 31 March 2018, (Summary Text) Sustainable Development

34. DAMAK TUTULUMU İLE EKSTRAMEDÜLLER NÜKS OLAN RELAPS REFRAKTER MULTİPLE MYELOM OLGUSU

ÇİFTÇİLER R., OKAY M., ALADAĞ KARAKULAK E., DEMİROĞLU H., GÖKER H.
3. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Cyprus (Kktc), 29 - 31 March 2018, (Summary Text)

35. EFFECT OF INDUCTION THERAPY ON SURVIVAL IN MULTIPLE MYELOMA PATIENTS

DEMİROĞLU H., ALADAĞ KARAKULAK E., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., SAYINALP N., et al.
INTERNATIONAL CONGRESS OF BMT 2018, Busan, South Korea, 30 August - 01 September 2018, vol.53, (Full Text)

36. A New Electrocardiographic Parameter in Scleroderma Patients with and Without Pulmonary Hypertension: Tp-E/Qtc Ratio

KARAKULAK U. N., Maharjan N., ALADAĞ KARAKULAK E., KILIÇ L., AKDOĞAN A., KAYA E. B., et al.
29th Turkish Cardiology Congress of the Turkish-Society-of-Cardiology (TSC) with International Participation, Antalya, Turkey, 26 - 29 October 2013, vol.62, (Summary Text)

37. Risk factors and Predictors in the Development of Pulmonary Hypertension in Scleroderma Patients

KARAKULAK U. N., Maharjan N., ALADAĞ KARAKULAK E., KILIÇ L., AKDOĞAN A., KAYA E. B., et al.
29th Turkish Cardiology Congress of the Turkish-Society-of-Cardiology (TSC) with International Participation, Antalya, Turkey, 26 - 29 October 2013, vol.62, (Summary Text)

38. Factors That Affect Pulmonary Artery Pressure in Scleroderma Patients with Pulmonary Hypertensoon

KARAKULAK U. N., Maharjan N., ALADAĞ KARAKULAK E., KILIÇ L., AKDOĞAN A., KAYA E. B., et al.
29th Turkish Cardiology Congress of the Turkish-Society-of-Cardiology (TSC) with International Participation, Antalya, Turkey, 26 - 29 October 2013, vol.62, (Summary Text)
Metrics

Publication

82

Publication (WoS)

41

Publication (Scopus)

36

Citation (WoS)

23

H-Index (WoS)

3

Citation (Scopus)

70

H-Index (Scopus)

6

Citation (TrDizin)

1

H-Index (TrDizin)

1

Citation (Sum Other)

1

Project

1

Thesis Advisory

3

Open Access

17
UN Sustainable Development Goals
SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING
SDG 4: GOAL 4: QUALITY EDUCATION
SDG 16: GOAL 16: PEACE, JUSTICE AND STRONG INSTITUTIONS
SDG 17: GOAL 17: PARTNERSHIPS FOR THE GOALS